Uncovering details of molecular Ferris wheels inside cell structures
Using the at the 's , a team at the Arizona State University Biodesign Institute has confirmed details of a molecular mechanism that cell organelles use to regulate the pH of their environment — and it looks a lot like a Ferris wheel.
Led by Abhishek Singharoy, a researcher at the Biodesign Center for Applied Structural Discovery (CASD) and Arizona State University's School of Molecular Sciences (SMS), the team used Summit to simulate molecular pumps that are embedded in the fatty outer membranes of cellular organelles, or cell structures that are specialized to perform different tasks for the cell's functioning. With rotors that spin 100 times per second, these pumps rapidly move protons — positively charged subatomic particles — into a cell's organelles to maintain the acidic environment inside that is crucial to the work they perform.
Using the nation's fastest supercomputer — the 's (OLCF's) Summit — the team uncovered a key step in how this mechanism works in one proton pump in particular, a yeast proton pump called vacuolar ATPase (V-ATPase) that is necessary for a variety of tasks in the body and has implications in disease. The results were .

"The V-ATPase proton pumps perform a wide range of functions, from helping transmit nerve signals to helping specialized cells secrete acid for maintaining bone," said Stephan Wilkens, a biochemist at SUNY Upstate Medical University and study co-author. "Malfunctions in these molecular machines contribute to diseases such as osteoporosis, neurodegeneration, diabetes, cancer, and AIDS, so understanding them is important for human health."
A team led by Wah Chiu—professor at the SLAC National Accelerator Facility and Stanford University and codirector of the Stanford-SLAC Cryo-EM Facilities—together with Wilkens and SLAC/Stanford postdoctoral researcher Soung-Hun Roh, had already that employed Cryogenic electron microscopy (cryo-EM) to study these proton pumps. Images from the work showed 10 amino acid "seats" on a molecular Ferris wheel that bind protons and carry them through the membrane to the organelle's interior, as well as other amino acids that catch them when they arrive. Based on that picture, the team working on the research suggested that the proton drop-off might be aided by water molecules—but their images were not sharp enough to confirm that the water molecules were there. In the same study, another round of even higher resolution cryo-EM images showed the water molecules around the suspected proton path.
Singharoy and his team used the Nanoscale Molecular Dynamics, or NAMD, code to perform simulations on the Summit supercomputer and confirmed that the experimentally observed water molecules line up to form "wires" at the proton drop-off point. These wires convey protons from their seats on the Ferris wheel to landing spots inside the organelle, like a fire brigade passing buckets hand to hand, bridging a gap they couldn't navigate on their own. The work was performed under the Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program at the OLCF.
The simulations matched the cryo-EM images nicely, providing strong evidence that the picture they painted of the proton drop-off is correct.
"Molecular motors exemplify some of the most intricate chemo-mechanical devices, and our team in SMS and CASD has developed highly sophisticated computational tools to address the energy source and sinks of the motor's ratcheting motion," Singharoy said. "In 2017 we started working on the soluble part of the V-type motor, namely, V1 ATPase. Now that we have a good control on the transmembrane Vo motor, it's a great step forward toward simulating the entire motor in collaboration with Hun, Stephan, and Wah."
Chiu said that recent advances in cryo-EM that allow imaging of individual particles at atomic resolution—even when they take slightly different shapes—will open new opportunities for using it as a tool to discover effective drugs for illnesses involving proton pumps.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.